CD44 and neoplasm: Overexpression of IL-1β in mammary 4T1 tumor cells can modify MDSC phenotype (more CD8, CD80, CD83, and CD14 expression and lower CD44 and B220) in vivo, while it does not change their capacity to dampen CD4 and CD8 T-cells’ activation/proliferation [132].